Melanoma research

Label

• Melanoma research (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi

• Combined treatment with thymosin-alpha 1 and low-dose interferon-alpha after dacarbazine in advanced melanoma. (Articolo in rivista) (Prodotto della ricerca)
• Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign nevi, dysplastic nevi, and primary melanomas along with their metastases. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• CDKN2A and MC1R analysis in amelanotic and pigmented melanoma (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• Recombinant interferon alpha-2b and coenzyme Q10 as a postsurgical adjuvant therapy for melanoma: a 3-year trial with recombinant interferon-alpha and 5-year follow-up (Articolo in rivista) (Prodotto della ricerca)
• Mutation analysis of candidate genes in melanoma-prone families: evidence of different pathogenetic mechanisms at chromosome 9p21. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• In vitro antitumour activity of resveratrol in human melanoma cells sensitive or resistant to temozolomide. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign nevi, dysplastic nevi, primary melano-mas along with their metastases. (Articolo in rivista) (Prodotto della ricerca)
• Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• Adjuvant therapy of melanoma: what?s new? (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)

Alternative label

• Melanoma res. (literal)

Language

• eng (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#issn

• 0960-8931 (literal)

Preferred label

• Melanoma research (literal)

Publisher

• Rapid Communications of Oxford. Oxford: GBR (literal)

Incoming links:

Rivista

• In vitro antitumour activity of resveratrol in human melanoma cells sensitive or resistant to temozolomide. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• Combined treatment with thymosin-alpha 1 and low-dose interferon-alpha after dacarbazine in advanced melanoma. (Articolo in rivista) (Prodotto della ricerca)
• Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign nevi, dysplastic nevi, primary melano-mas along with their metastases. (Articolo in rivista) (Prodotto della ricerca)
• CDKN2A and MC1R analysis in amelanotic and pigmented melanoma (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• Adjuvant therapy of melanoma: what?s new? (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• Recombinant interferon alpha-2b and coenzyme Q10 as a postsurgical adjuvant therapy for melanoma: a 3-year trial with recombinant interferon-alpha and 5-year follow-up (Articolo in rivista) (Prodotto della ricerca)
• Mutation analysis of candidate genes in melanoma-prone families: evidence of different pathogenetic mechanisms at chromosome 9p21. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign nevi, dysplastic nevi, and primary melanomas along with their metastases. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)